Increased serum interleukin-5 and vascular endothelial growth factor in children with acute mycoplasma pneumonia and wheeze

Pediatric Pulmonology

Volumn 44, Issue 5, 2009, Pages 423-428

  Choi, Ic Sun ^a   Byeon, Jung Hye ^a   Yoo, Young ^a   Lee, Kwang Chul ^a   Choung, Ji Tae ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Children; Interleukin 5; Mycoplasma pneumonia; Vascular endothelial growth factor; Wheeze

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; VASCULOTROPIN;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; WHEEZING;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-5; MALE; PNEUMONIA, MYCOPLASMA; RESPIRATORY SOUNDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66749157429     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20961     Document Type: Article

References (33)

1. Shehab ZM. Mycoplasma infections. In: Taussig LM, Landau LI, editors. Pediatric respiratory medicine. Philadelphia: Mosby; 1999. pp. 737-742.
2. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003;36:267-278.
3. Esposito S, Principi N. Asthma in children: are Chlamydia or Mycoplasma involved? Pediatr Drugs 2001;3:159-168.
4. Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, Gouarin S, Duhamel JF, Guillois B. Detection ofviral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999;13:131 -139.
5. Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child 1984;59:1034-1037.
6. Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, Heilbronner C, Iniguez JL, Chaussain M, Nicand E, Raymond J, Gendrel D. Mycoplasma pneumoniae and asthma in children. Clin Infec Dis 2004;38:1341 -1346.
7. Weinberger M. Respiratory infections and asthma: current treatment strategies. Drug Discov Today 2004;1:831 -837.
8. Martin RJ, Kraft M, Chu HW, Berns EA, Cassell GH. A link between chronic asthma and chronic infection. J Allergy Clin Immunol 2001;107:596-601.
9. Esposito S, Droghetti R, Bosis S, Claut L, Marchisio P, Principi N. Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze. Pediatr Pulmonol 2002;34: 122-127.
10. Chung HL, Kim SG, Shin IH. The relationship between serum endothelin (ET)-1 and wheezing status in the children with Mycoplasma pneumoniae pneumonia. Pediatr Allergy Immunol 2006;17:285-290.
11. McColley SA, Stellmach V, Boas SR, Jain M, Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 2000;161:1877- 1880.
12. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301.
13. Kanazawa H, Asai K, Nomura S. Vascular endothelial growth factor as a non-invasive marker of pulmonary vascular remodeling in patients with bronchitis-type of COPD. Respir Res 2007;8:22.
14. Nishigaki Y, Fujiuchi S, Yamazaki Y, Matsumoto H, Takeda A, Fujita Y, Okamoto K, Fujikane T, Shimizu T, Kikuchi K. Increased vascular endothelial growth factor in acute eosinophilic pneumonia. Eur Respir J 2003;21:774-778.
15. Shee CD. Wheeze and Mycoplasma pneumoniae. J R Soc Med 2002;95:132-133.
16. Seo Y, Yu BK, Oh YJ, Lee Y, Yoo Y, Choung JT, Koh YY. Increased vascular endothelial growth factor in children with acute Mycoplasma pneumoniae pneumonia and wheezing. Korean J Pediatr 2008;51:487 -491.
17. Nakajima H, Takatsu K. Role of cytokines in allergic airway inflammation. Int Arch Allergy Immunol 2007;142:265-273.
18. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
19. Choi SH, Park EY, Jung HL, Shim JW, Kim DS, Park MS, Shim JY. Serum vascular endothelial growth factor in pediatric patients with community-acquired pneumonia and pleural effusion. J Korean Med Sci 2006;21:608-613.
20. Seggev JS, Sedmak GV, Kurup V. Isotype-specific antibody response to acute Mycoplasma pneumoniae infection. Ann Allergy Asthma Immunol 1996;77:67-73.
21. Ruuth E, Praz F. Interactions between mycoplasmas and the immune system. Immunol Rev 1989;112:133-160.
22. Nakayama T, Urano T, Osano M, Maehara N, Makino S. Alpha interferon in the sera of patients infected with Mycoplasma pneumoniae. J Infect Dis 1986;154:904-906.
23. Makhoul N, Merchav S, Tatarsky I, Naot Y. Mycoplasma-induced in vitro production of interleukin-2 and colony-stimulating activity. Isr J Med Sci 1987;23:480-484.
24. Pietsch K, Ehlers S, Jacobs E. Cytokine gene expression in the lungs of BALB/c mice during primary and secondary intranasal infection with Mycoplasma pneumoniae. Microbiology 1994; 140:2043 -2048.
25. Kitahara H, Yamashita R, Kanemitsu T, Niwa I, Osano M. Relationship between M. pneumoniae infections and eosinophilia. Proceedings of the 12th Annual Congress of the Japanese Society of Mycoplasmology 1985. 75-78.
26. Yamashita R, Kitahara H, Kanemitsu T, Takeda T, Yamaguchi S. Eosinophil cationic protein in the sera of patients with mycoplasma pneumonia. Pediatr Infect Dis J 1994;13:379-381.
27. Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA 1986;83:3146- 3150.
28. Motojima S, Frigas E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989;139:801 -805.
29. Koh YY, Park Y, Lee HJ, Kim CK. Levels of interleukin-2, interferon-g, and interleukin-4 in bronchoalveolar lavage fluid from patients with mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 2001;107:e39.
30. Salvatore CM, Fonseca-Aten M, Karz-Gaynor K, Gomez AM, Mejias A, Somers C, Chavez-Bueno S, McCracken GH, Hardy RD. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infect Immun 2007;75:236-242.
31. Nakayama T, SonodaS,Urano T, OsanoM, MaeharaN, Sasaki K, Hayatsu E, Makino S. Interferon production during the course of Mycoplasma pneumoniae infection. Pediatr Infect Dis J 1992;11:72-77.
32. Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001;24:577-582.
33. Johnston SL, Martin RJ. Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 2005;172:1078-1089.